Vanta Bioscience (BOM:540729) Construction In Progress: ₹0.00 Mil (As of Mar. 2026)


BOM:540729 Vanta Bioscience Ltd BOM:540729
57 GF Score
Price ₹25.29
GF Value ₹12.03
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Vanta Bioscience Construction In Progress?

Vanta Bioscience BOM:540729 57 Construction In Progress is ₹0.00 Mil as of Mar. 2026. GuruFocus rates BOM:540729 with a GF Score™ of 57/100 and a GF Value™ of ₹12.03 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Vanta Bioscience Construction In Progress Historical Data

* Premium members only.

The historical data trend for Vanta Bioscience's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vanta Bioscience Construction In Progress Chart

Vanta Bioscience Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 227.80 0.00 0.00 0.00 0.00

Vanta Bioscience Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:540729
57GF Score
Vanta Bioscience Ltd BOM:540729
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vanta Bioscience Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹0.00 Mil mean?
Vanta Bioscience (BOM:540729) has a Construction In Progress of ₹0.00 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Vanta Bioscience and its competitors.
Is Vanta Bioscience's Construction In Progress too high?
Vanta Bioscience's current Construction In Progress is ₹0.00 Mil. Overall, Vanta Bioscience has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vanta Bioscience's Construction In Progress compare to TMO and DHR?
Vanta Bioscience's Construction In Progress of ₹0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Diagnostics & Research company?
A good Construction In Progress depends on the Medical Diagnostics & Research industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Vanta Bioscience and its competitors. Vanta Bioscience's current Construction In Progress is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vanta Bioscience stock overvalued right now?
Based on GuruFocus' analysis, Vanta Bioscience (BOM:540729) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹12.03, compared to a current price of ₹25.29 — trading 110.2% above its estimated fair value. The current Construction In Progress is ₹0.00 Mil. Vanta Bioscience's overall GF Score™ is 57/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Vanta Bioscience (BOM:540729), the current Construction In Progress is ₹0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vanta Bioscience (BOM:540729) Overvalued in 2026?

Based on GuruFocus' analysis, Vanta Bioscience stock appears to be overvalued. The current stock price of ₹25.29 is trading 110.2% above its estimated GF Value™ of ₹12.03. GuruFocus considers Vanta Bioscience to be Significantly Overvalued.

Key valuation signals for BOM:540729:

  • Construction In Progress: ₹0.00 Mil
  • GF Value™: ₹12.03 vs. price of ₹25.29 (110.2% above fair value)
  • GF Score™: 57/100 with 10 warning signs

No single metric tells the full story. See the BOM:540729 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vanta Bioscience Business Description

Address No. 02/G/308/G, Umajay Complex, No. 3/FF/SF/1-20-248, Rasoolpura, Secunderabad, TG, IND, 500003
Vanta Bioscience Ltd is a full-service preclinical contract research organization based in Chennai, India, providing preclinical safety assessment services for the pharmaceutical, medical devices, nutraceuticals, biotech, agrochemicals, cosmetics, chemical, and feed additive industries. Established as a center of excellence in GLP-compliant toxicology and safety assessment, the company supports clients through toxicology studies, batch release tests, biocompatibility evaluations, agro-chemical and chemical safety assessments, and diet formulation services. It also offers testing and contract research services in clinical and pre-clinical research, biopharma studies, analytical testing, and environmental assessments.
57GF Score

Get the complete analysis for BOM:540729

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹25.29
Price
₹12.03
GF Value